Menu
GeneBe

PCBD1

pterin-4 alpha-carbinolamine dehydratase 1

Basic information

Region (hg38): 10:70882279-70888565

Previous symbols: [ "DCOH", "PCBD" ]

Links

ENSG00000166228NCBI:5092OMIM:126090HGNC:8646Uniprot:P61457AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • pterin-4 alpha-carbinolamine dehydratase 1 deficiency (Definitive), mode of inheritance: AR
  • pterin-4 alpha-carbinolamine dehydratase 1 deficiency (Strong), mode of inheritance: AR
  • pterin-4 alpha-carbinolamine dehydratase 1 deficiency (Moderate), mode of inheritance: AR
  • pterin-4 alpha-carbinolamine dehydratase 1 deficiency (Strong), mode of inheritance: AR
  • pterin-4 alpha-carbinolamine dehydratase 1 deficiency (Supportive), mode of inheritance: AR
  • pterin-4 alpha-carbinolamine dehydratase 1 deficiency (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Hyperphenylalaninemia, BH4-deficient, DARRenalIn addition to other findings, patients may develop hypomagnesemia with renal magnesium loss, and awareness may allow medical management (magnesium supplementation), which has been reported as clinically beneficialBiochemical; Endocrine; Renal8352282; 9585615; 9760199; 24204001; 24848070
Individuals have been treated with phenylalanine restriction and BH4 supplementation, but such interventions may not be indicated

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PCBD1 gene.

  • Pterin-4 alpha-carbinolamine dehydratase 1 deficiency (63 variants)
  • not provided (16 variants)
  • Inborn genetic diseases (2 variants)
  • BH4-Deficient Hyperphenylalaninemia (1 variants)
  • - (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PCBD1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
15
clinvar
15
missense
2
clinvar
12
clinvar
1
clinvar
15
nonsense
2
clinvar
2
start loss
0
frameshift
4
clinvar
2
clinvar
6
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
3
3
non coding
7
clinvar
17
clinvar
9
clinvar
33
Total 4 6 19 33 9

Highest pathogenic variant AF is 0.0000131

Variants in PCBD1

This is a list of pathogenic ClinVar variants found in the PCBD1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-70883544-AAC-A BH4-Deficient Hyperphenylalaninemia Uncertain significance (Jun 14, 2016)300341
10-70883697-A-T Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Benign/Likely benign (Mar 29, 2019)300342
10-70883834-G-A Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Uncertain significance (Jan 12, 2018)300343
10-70883836-C-T Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Likely benign (Jan 13, 2018)300344
10-70883843-G-A Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Uncertain significance (Jan 12, 2018)879954
10-70883914-C-T Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Benign (Sep 05, 2021)300345
10-70883921-C-T Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Uncertain significance (Jan 13, 2018)300346
10-70883952-A-G Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Conflicting classifications of pathogenicity (Jul 05, 2022)428616
10-70883957-A-T Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Uncertain significance (Feb 19, 2022)2099511
10-70883965-T-G Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Likely benign (Dec 22, 2023)2971771
10-70883971-T-C Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Conflicting classifications of pathogenicity (Jan 19, 2024)1508980
10-70883973-G-A Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Pathogenic/Likely pathogenic (Jan 18, 2024)16799
10-70883976-C-T Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Likely pathogenic (Dec 23, 2023)91907
10-70883977-G-A Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Likely benign (May 31, 2023)2177603
10-70883979-T-C Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Uncertain significance (Oct 03, 2022)2046343
10-70883984-C-A Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Uncertain significance (Sep 01, 2021)948589
10-70883992-GT-G Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Pathogenic (May 28, 2019)802585
10-70883995-T-G Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Likely benign (Jan 18, 2024)3022206
10-70884001-C-G Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Likely benign (Dec 27, 2023)1118849
10-70884002-C-T Pterin-4 alpha-carbinolamine dehydratase 1 deficiency • Inborn genetic diseases • PCBD1-related disorder Likely benign (Jan 30, 2024)242621
10-70884003-G-A Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Uncertain significance (Jun 13, 2022)1384033
10-70884003-G-T Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Likely benign (May 22, 2023)2778732
10-70884006-C-A Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Pathogenic/Likely pathogenic (Jan 08, 2024)16795
10-70884011-AGG-CACCCATGGTGAGCAC Likely pathogenic (Sep 01, 2022)2640562
10-70884013-G-A Pterin-4 alpha-carbinolamine dehydratase 1 deficiency Likely benign (Jun 02, 2023)2778189

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PCBD1protein_codingprotein_codingENST00000299299 46505
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0003320.3831257230251257480.0000994
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7164257.20.7340.00000338693
Missense in Polyphen1622.6960.70497265
Synonymous-0.4862724.01.130.00000150189
Loss of Function-0.10754.751.052.07e-762

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001160.000116
Ashkenazi Jewish0.001290.00129
East Asian0.0001090.000109
Finnish0.000.00
European (Non-Finnish)0.00003520.0000352
Middle Eastern0.0001090.000109
South Asian0.00003270.0000327
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in tetrahydrobiopterin biosynthesis. Seems to both prevent the formation of 7-pterins and accelerate the formation of quinonoid-BH2. Coactivator for HNF1A-dependent transcription. Regulates the dimerization of homeodomain protein HNF1A and enhances its transcriptional activity.;
Disease
DISEASE: Hyperphenylalaninemia, BH4-deficient, D (HPABH4D) [MIM:264070]: An autosomal recessive disease characterized by primapterinuria, a variant form of hyperphenylalaninemia defined by increased excretion of 7-substituted pterins in the urine. Patients with primapterinuria show an increased ratio of neopterin to biopterin in the urine, excretion of subnormal levels of biopterins, and normal levels of biogenic amines in cerebrospinal fluid. Neurologic signs are mild, present in the neonatal period only, and include hypotonia, delayed motor development and tremor. {ECO:0000269|PubMed:8352282, ECO:0000269|PubMed:9760199}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Folate biosynthesis - Homo sapiens (human);phenylalanine degradation/tyrosine biosynthesis;Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism;Metabolism of amino acids and derivatives;Phenylalanine and tyrosine catabolism;Biopterin metabolism;Metabolism (Consensus)

Recessive Scores

pRec
0.230

Intolerance Scores

loftool
0.574
rvis_EVS
0.01
rvis_percentile_EVS
54.63

Haploinsufficiency Scores

pHI
0.300
hipred
Y
hipred_score
0.553
ghis
0.569

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.973

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pcbd1
Phenotype
renal/urinary system phenotype; vision/eye phenotype; pigmentation phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);

Gene ontology

Biological process
L-phenylalanine catabolic process;tetrahydrobiopterin biosynthetic process;regulation of protein homodimerization activity;positive regulation of transcription, DNA-templated;protein homotetramerization;protein heterooligomerization;oxidation-reduction process
Cellular component
nucleus;nucleoplasm;cytosol;extracellular exosome
Molecular function
transcription coactivator activity;phenylalanine 4-monooxygenase activity;protein binding;4-alpha-hydroxytetrahydrobiopterin dehydratase activity;identical protein binding